C5: AI in Drug and Therapeutic Discovery: Navigating Patent Challenges and New Regulatory Landscapes
- Exploring the impact of the European Union’s AI Act, the first comprehensive AI law, on AI in drug discovery
- Examining the increasing trend of patent filings related to AI and machine learning in drug discovery
- Developing strategies for patenting AI innovations, including the challenges of meeting patentability criteria like novelty and non-obviousness
- Analyzing the importance of data exclusivity in AI-driven drug discovery, focusing on strategies for protecting proprietary data and the implications for patent enforcement
- Addressing the challenges of managing IP for AI-assisted drug discovery in a global context, taking into account different regulatory environments and the need for harmonized strategies